219 related articles for article (PubMed ID: 8887644)
1. Naturally occurring dominant negative variants of Stat5.
Wang D; Stravopodis D; Teglund S; Kitazawa J; Ihle JN
Mol Cell Biol; 1996 Nov; 16(11):6141-8. PubMed ID: 8887644
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
4. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation.
Ilaria RL; Hawley RG; Van Etten RA
Blood; 1999 Jun; 93(12):4154-66. PubMed ID: 10361113
[TBL] [Abstract][Full Text] [Related]
5. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
6. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
Chida D; Wakao H; Yoshimura A; Miyajima A
Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603
[TBL] [Abstract][Full Text] [Related]
8. A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation.
Barber DL; Beattie BK; Mason JM; Nguyen MH; Yoakim M; Neel BG; D'Andrea AD; Frank DA
Blood; 2001 Apr; 97(8):2230-7. PubMed ID: 11290583
[TBL] [Abstract][Full Text] [Related]
9. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.
Matsumoto A; Masuhara M; Mitsui K; Yokouchi M; Ohtsubo M; Misawa H; Miyajima A; Yoshimura A
Blood; 1997 May; 89(9):3148-54. PubMed ID: 9129017
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
Yamashita H; Iwase H; Toyama T; Fujii Y
Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867
[TBL] [Abstract][Full Text] [Related]
11. Genomic structure, expression and characterization of a STAT5 homologue from pufferfish (Tetraodon fluviatilis).
Sung SC; Fan TJ; Chou CM; Leu JH; Hsu YL; Chen ST; Hsieh YC; Huang CJ
Eur J Biochem; 2003 Jan; 270(2):239-52. PubMed ID: 12605675
[TBL] [Abstract][Full Text] [Related]
12. Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation.
Grimley PM; Dong F; Rui H
Cytokine Growth Factor Rev; 1999 Jun; 10(2):131-57. PubMed ID: 10743504
[TBL] [Abstract][Full Text] [Related]
13. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
Friedrich K; Wietek S
Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
[TBL] [Abstract][Full Text] [Related]
14. Specific DNA binding and transactivation potential of recombinant, purified Stat5.
Beisenherz-Huss C; Mundt M; Herrala A; Vihko P; Schubert A; Groner B
Mol Cell Endocrinol; 2001 Oct; 183(1-2):101-12. PubMed ID: 11604230
[TBL] [Abstract][Full Text] [Related]
15. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Silva CM; Lu H; Day RN
Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
[TBL] [Abstract][Full Text] [Related]
16. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
Liu X; Robinson GW; Gouilleux F; Groner B; Hennighausen L
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8831-5. PubMed ID: 7568026
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of STAT5 by a point mutation in the SH2 domain.
Ariyoshi K; Nosaka T; Yamada K; Onishi M; Oka Y; Miyajima A; Kitamura T
J Biol Chem; 2000 Aug; 275(32):24407-13. PubMed ID: 10823841
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
19. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
20. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
